CORZ - Core Scientific, Inc. Stock Analysis | Stock Taper
Logo
Core Scientific, Inc.

CORZ

Core Scientific, Inc. NASDAQ
$16.97 -5.62% (-1.01)

Market Cap $5.26 B
52w High $23.63
52w Low $6.20
P/E -7.86
Volume 9.03M
Outstanding Shares 310.06M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $81.1M $69.22M $-146.66M -180.83% $-0.46 $-127.46M
Q2-2025 $78.63M $31.31M $-936.8M -1.19K% $-0.04 $-634K
Q1-2025 $79.53M $50.81M $580.69M 730.2% $1.44 $-20.18M
Q4-2024 $94.92M $44.55M $-265.54M -279.74% $-0.6 $-234.88M
Q3-2024 $95.35M $41.06M $-455.26M -477.44% $-1.56 $-418.31M

What's going well?

Revenue is holding steady and the net loss is much smaller than last quarter, mainly thanks to a big boost from 'other' income. No interest expense means the company isn't weighed down by debt.

What's concerning?

Core operating losses are growing fast, costs are rising much faster than sales, and margins are shrinking. The improvement in net loss is mostly due to non-operating items, not better business performance.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $453.44M $2.3B $3.42B $-1.13B
Q2-2025 $581.35M $1.98B $3.04B $-1.06B
Q1-2025 $697.94M $1.63B $1.81B $-181.51M
Q4-2024 $836.2M $1.6B $2.42B $-820.18M
Q3-2024 $253.02M $921.85M $1.65B $-729.39M

What's financially strong about this company?

The company has a solid base of physical assets and no risky goodwill or intangibles. Current assets still cover short-term bills, and deferred revenue provides some cash cushion.

What are the financial risks or weaknesses?

Negative equity, shrinking cash, and a long history of losses are major red flags. Heavy debt and no shareholder cushion mean the company is financially fragile.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-146.66M $131.78M $-254.36M $-5.32M $-127.9M $-122.84M
Q2-2025 $-936.8M $34M $-119.61M $-31.77M $-117.38M $-87.28M
Q1-2025 $580.69M $-40.6M $-93.46M $-4.2M $-138.25M $-129.02M
Q4-2024 $-184.79M $13.8M $-28.8M $598.17M $583.18M $-14.95M
Q3-2024 $-455.26M $5.71M $-31.24M $182.22M $156.7M $-25.34M

What's strong about this company's cash flow?

Operating cash flow improved dramatically to $132 million, showing the core business can generate cash. Net losses are mostly accounting, not real cash burn.

What are the cash flow concerns?

Free cash flow is deeply negative due to heavy investments, and cash reserves are shrinking quickly. The boost from working capital is likely temporary, and ongoing cash burn could become a problem.

Revenue by Products

Product Q2-2023Q3-2023Q4-2023Q1-2024
Digital Asset Mining Service
Digital Asset Mining Service
$0 $80.00M $210.00M $150.00M
Hosting Service
Hosting Service
$20.00M $20.00M $20.00M $20.00M
Equipment Sales
Equipment Sales
$0 $0 $0 $0

Q1 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Core Scientific, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Core Scientific’s key strengths include a large and strategically located power and data center footprint, operational experience with high-density and energy-intensive computing, and proprietary management software that can scale across vast fleets of devices. The recent improvement in liquidity gives it short-term breathing room, and the pivot toward AI and HPC hosting positions it in a segment where demand is robust. Its ability to repurpose existing facilities offers a structural time-to-market advantage that many competitors lack.

! Risks

Major risks cluster around financial fragility and execution. The company has a history of very large losses, negative equity, and dependence on external financing, all of which raise questions about long-term solvency if conditions worsen. Free cash flow has been negative in most years, and leverage is high. Strategically, it faces the twin challenges of crypto market volatility and intense competition in AI infrastructure, combined with customer concentration and ongoing heavy capital needs. Any misstep in scaling HPC, securing diversified contracts, or controlling costs could quickly strain its balance sheet.

Outlook

The outlook is highly mixed and carries substantial uncertainty. On one hand, Core Scientific owns valuable assets and capabilities that are well aligned with rising demand for AI and HPC computing, and it has shown a willingness to innovate and reject deals it views as undervaluing its standalone potential. On the other hand, its financial track record is weak, its capital structure is stressed, and its business remains exposed to cyclical and volatile markets. Future performance will largely depend on how quickly and profitably it can grow its HPC and hosting operations, improve margin discipline, and convert its strengthened liquidity into a sustainable, self-funding business model.